Switch to:
More From Other Websites
Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ... Dec 15 2014
CytRx Falls on Written FDA Notice for Aldoxorubicin Study Dec 04 2014
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical... Dec 03 2014
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical... Dec 03 2014
CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 02 2014
CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 02 2014
CytRx Falls on Partial Study Hold on Oncology Candidate Nov 19 2014
FDA puts partial hold on CytRx cancer drug trials Nov 18 2014
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials Nov 18 2014
CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials Nov 18 2014
Amarantus passe un accord d’option exclusive pour l’acquisition auprès de Lonza d’un... Nov 17 2014
CYTRX CORP Financials Nov 14 2014
10-Q for CytRx Corp. Nov 06 2014
CytRx Reports 2014 Third Quarter Financial Results Nov 04 2014
CYTRX CORP Files SEC form 10-Q, Quarterly Report Nov 04 2014
CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition Nov 04 2014
CytRx Reports 2014 Third Quarter Financial Results Nov 04 2014
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium Oct 30 2014
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium Oct 30 2014
CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia Oct 29 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK